Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa, Yoshinori Ito, Takashi Oyama, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Hiroshi Kawachi, Shiko Kuribayashi, Koji Kono, Takashi Kojima, Hiroya Takeuchi, Takahiro Tsushima, Yasushi Toh, Kenji Nemoto, Eisuke Booka, Tomoki Makino, Satoru Matsuda, Hisahiro Matsubara, Masayuki Mano, Keiko Minashi, Tatsuya Miyazaki, …Masahiro Yoshida
PURPOSE: The primary objective of these guidelines was to provide general clinicians with information that would guide them to make informed choices from the available diagnosis/treatment strategies for esophageal cancer (intended only for malignant esophageal tumors of epithelial origin, and not for any other non-epithelial malignant tumors of the esophagus or metastatic malignant esophageal tumors).
These guidelines are intended as an aid for healthcare professionals other than physicians, and also for patients and their family members, to help them understand the fundamental principles of the diagnosis and treatment of esophageal cancer.
Esophageal Cancer Practice Guidelines 2022 (JES) PART 1
Esophageal Cancer Practice Guidelines 2022 (JES) Part 2
.png){kind=logo}
